Difference between revisions of "Poorly differentiated carcinoma of the lung"
Jump to navigation
Jump to search
Line 6: | Line 6: | ||
*Should be used when the DDx is ''small cell carcinoma'' versus ''non-small cell carcinoma''. | *Should be used when the DDx is ''small cell carcinoma'' versus ''non-small cell carcinoma''. | ||
*''Poorly differentiated carcinoma'' leaves the surgical options on the table. | *''Poorly differentiated carcinoma'' leaves the surgical options on the table. | ||
Clinical: | |||
*Radiologic findings should not be suggestive of a metastasis. | |||
==Microscopic== | ==Microscopic== |
Revision as of 03:53, 18 November 2015
Poorly differentiated carcinoma of the lung, also poorly differentiated lung carcinoma, is an unclassified lung tumour with features of small cell carcinoma and non-small cell lung carcinoma.
Categorically, it is grouped with non-small cell lung cancer.
General
- Should be used when the DDx is small cell carcinoma versus non-small cell carcinoma.
- Poorly differentiated carcinoma leaves the surgical options on the table.
Clinical:
- Radiologic findings should not be suggestive of a metastasis.
Microscopic
Features:
- Small cell carcinoma/basaloid squamous cell carcinoma-like tumour.
DDx:
- Lung metastasis - history and imaging important.
- Small cell carcinoma of the lung.
- Squamous cell carcinoma of the lung.
IHC
- Lack of staining with neuroendocrine markers (chromogranin A -ve, synaptophysin -ve, CD56 -ve).
- Keratins +ve.
Sign out
Lung, Left Lower Lobe, Core Biopsy: - POORLY DIFFERENTIATED CARCINOMA, see comment. COMMENT: The tumour stains as follows: POSITIVE: EMA, AE1/AE3. NEGATIVE: TTF-1, chromogranin A, synaptophysin, CD56, CD45, CK5/6, p63. The morphology would be compatible with small cell carcinoma or basaloid squamous cell carcinoma. The neuroendocrine markers (chromogranin A, synaptophysin, CD56) and the squamoid markers available (p63, CK5/6) are negative; thus, the tumour is not further classified.